Podcast: Comprehensive care for sickle cell disease
The Children’s Health℠ Sickle Cell Disease Program cares for approximately 900 children annually with various forms of sickle cell disease. Patients have access to our comprehensive and multidisciplinary clinics on both the Dallas and Plano campuses led by specialists from the UT Southwestern Pediatric Group. From the beginning, the team has been dedicated to the development of innovative treatment approaches. UT Southwestern was recently named as the lead site for the newly created North Texas Sickle Cell Disease Clinical Trial Unit (ASH Collaborative), a sickle cell disease clinical trials network aimed at bringing new therapies to individuals with sickle cell disease.
In this podcast, Lincy Thomas, M.D., Pediatric Hematologist/Oncologist at Children’s Health and Assistant Professor at UT Southwestern, discusses how the team provides comprehensive care, the types of treatments used for patients and what sets the program apart.
Listen to learn about state-of-the-art approaches to infection prevention, pain management and treatment of specific organ-related complications.
About the Sickle Cell Disease Program
The Children’s Health Sickle Cell Disease Program helps prevent complications from sickle cell disease, offers the most innovative treatments and provides pain management techniques to help kids feel better.
About Dr. Lincy Thomas
Lincy Thomas, M.D. is a Pediatric Hematologist/Oncologist at Children’s Health and Assistant Professor at UT Southwestern. She earned her medical degree from Texas Tech University Health Sciences Center School of Medicine and completed her residency in pediatrics at University of Oklahoma Health Sciences Center. Learn more about Dr. Thomas.
Pediatric Insights: Advances and Innovations with Children’s Health
Pediatric Insights is a medical podcast that explores the latest in pediatric care and research. Experts from Children’s Health discuss advances and innovations as they encounter some of the most complex pediatric conditions.
Find the latest innovation, clinical trial and research articles.